Dinalbuphine Sebacate in Postoperative Pain Control After TKA
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age50-90
SponsorThammasat University
About this trial
To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty
Eligibility criteria
Qualifiers
Osteoarthritic knee patients underwent unilateral primary TKA
Age 50-90 years
ASA class I-III
Participants understand and consent to the protocol of the trial
Disqualifiers
Morbid obesity (BMI>40)
Knee osteoarthritis from inflammatory knee arthritis, trauma, infection
Previous knee surgery
Cognitive disorder
Trial design
Treatments tested in this trial
- Dinalbuphine Sebacate
- Normal Saline
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
1Thammasat University12120, Khlong LuangChangwat Pathum Thani, Thailand
Sponsors and collaborators
Thammasat University
Lead sponsor
Source ClinicalTrials.gov